Latest Breaking News On - Kathleen farren - Page 1 : vimarsana.com

Merus Announces Publication of Abstracts on MCLA-129 for Presentation at ESMO Asia Congress 2023

Merus Announces Publication of Abstracts on MCLA-129 for Presentation at ESMO Asia Congress 2023
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United kingdomKathleen farrenZenocutuzumab zenoSherri spearDevelopment strategyIr corp commsGlobenewswire incEuropean society for medical oncologyCompany conference callExchange commissionSasia congressEarly access programCorporate communicationsMedical oncologyChief executive officerResponse evaluation criteria

Merus Announces Abstracts Accepted for Presentation at the ESMO Asia Congress 2023

Mini Oral: MCLA-129 in combination with osimertinib in treatment naïve, and after progression on osimertinib, non-small cell lung cancer Poster: MCLA-129 in previously treated head & neck squamous cell carcinoma UTRECHT, The Netherlands and CAMBRIDGE, Mass., Oct. 06, 2023 (GLOBE NEWSWIRE) Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced the acc

United kingdomSherri spearKathleen farrenSasia congressCorp commsCorporate communicationsExchange commissionEuropean society for medical oncology congressMini oralEuropean societyMedical oncology congressSingapore decemberMerus dockPrivate securities litigation reform actAnnual reportBispecific antibody

Merus N V : Merus Announces Abstracts Accepted for Presentation at the ESMO Asia Congress 2023

Merus N V : Merus Announces Abstracts Accepted for Presentation at the ESMO Asia Congress 2023
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomKathleen farrenSherri spearCorp commsSasia congressEuropean society for medical oncology congressCorporate communicationsExchange commissionMini oralEuropean societyMedical oncology congressSingapore decemberMerus dockPrivate securities litigation reform actAnnual reportAktien sie

Merus N V (MRUS) Reports Zenocutuzumab granted Breakthrough Therapy Designation by FDA

Merus N V (MRUS) Reports Zenocutuzumab granted Breakthrough Therapy Designation by FDA
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSherri spearKathleen farrenDrug administrationExchange commissionEarly access programCorporate communicationsAmerican society of clinical oncology annual meetingsIr corp commsBreakthrough therapy designationFast track designationOrphan drug designationClinical oncology annual meetingsBiologics license applicationBill lundbergChief executive officer

Merus N V : Merus to Participate in a Fireside Chat at the Jefferies Virtual Healthcare Conference

Merus N.V.: Merus to Participate in a Fireside Chat at the Jefferies Virtual Healthcare Conference and Triclonics ), today announced that Bill Lundberg, M.D., Chief Executive Officer of Merus, will participate in a fireside chat at the Jefferies Virtual Healthcare Conference on Wednesday, June 2 at 9:00 a.m. ET. The live webcast of the presentation will be available on the Investors page of the Company s website. An archived presentation will be available on the Merus website for a limited time. About Merus Merusis a clinical-stage oncology company developing innovative full-length human bispecific and trispecific antibody therapeutics, referred to as Multiclonics

United kingdomKathleen farrenCommunications specialistBill lundbergChief executive officerJefferies virtual healthcare conferenceMedia inquiriesஒன்றுபட்டது கிஂக்டம்க்யாத்லீந் ஃப்யாரந்தகவல்தொடர்புகள் நிபுணர்ர சி து லண்ட்பெர்க்தலைமை நிர்வாகி அதிகாரிஜெஃப்பெரிஸ் மெய்நிகர் சுகாதாரம் மாநாடுமீடியா விசாரணைகள்